GlassScriptPhysician profile
Ryan Christopher Merson
NPI 1184967234
$8,948.66
in general payments reported to CMS, 2019-2025
21 companies · $2,435 in 2025
The $2,435 reported for 2025 was more than what 93% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $337 · 2022: $678 · 2023: $2,339 · 2024: $3,161 · 2025: $2,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,744 · Travel and Lodging: $2,188 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,744.47 |
| Travel and Lodging | $2,187.89 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,775.28 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Abbott Laboratories | $2,831.25 | 2021-2025 | Mitraclip, Navitor, Triclip |
| Boston Scientific Corporation | $314.10 | 2022-2025 | Watchman Flx, Farapulse |
| Baxter Healthcare | $245.73 | 2023-2024 | Preveleak, Floseal, Tisseel |
| Medtronic, INC. | $151.78 | 2025 | Corevalve Evolut R |
| Cvrx, INC. | $121.48 | 2023 | Barostim Neo System |
| Pfizer INC. | $74.14 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.24 | 2021-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $44.14 | 2022-2023 | |
| Heartflow, INC. | $40.99 | 2024 | |
| Esperion Therapeutics, INC. | $40.23 | 2021-2024 | Nexletol |
| Janssen Pharmaceuticals, INC | $39.78 | 2023-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $37.15 | 2024 | Arcalyst |
| Amgen INC. | $34.90 | 2023-2024 | Repatha |
| W. L. Gore & Associates, INC. | $25.53 | 2024 | Gore Cardioform Septal Occluder |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $23.43 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.56 | 2024 | Lifevest |
| Merck Sharp & Dohme LLC | $19.58 | 2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $18.00 | 2024 | Camzyos |
| Inari Medical, INC. | $14.97 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $14.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Merson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.